Digital Patient Education Platform in Head and Neck Cancer

NCT05211778 | Unknown

• 1 other identifier: H16-01039
• Study Type: interventional
• Target: 35
• Locations: 1 country
• Sites: 1

Brief Summary

Head and neck cancer is a disease that has a particular propensity for treatment-related morbidity. It is hypothesized that patients who are more involved in their care in hospital and who are actively provided with more treatment-related education may report increased satisfaction and have improved overall outcomes. The investigators aim to determine whether delivery of patient-centred education in a multimedia format via a digital platform has an impact on overall satisfaction and perceived quality of medical care.

Conditions

Head and Neck Cancer

Keywords

Education; Patient Satisfaction; Multimedia; Free flap; Head and neck cancer

Outcome Measures

Primary Outcomes (1)

• Patient Satisfaction

  Measured via a 5-point Likert scale from a survey collected on discharge day

  From date of surgery until the date of discharge. The number of days patients will remain in hospital after surgery can range from 7-14 days.

Secondary Outcomes (1)

• Perceived quality of medical care

  From date of surgery until the date of discharge. The number of days patients will remain in hospital after surgery can range from 7-14 days.

Study Arms (2)

Control Group

NO INTERVENTION

This group will continue to receive the routine standard of care during their treatment journey.

Digital Education Group

EXPERIMENTAL

In addition to the standard of care, this group will complete an audiovisual digital education module during their postoperative stay in hospital.

Behavioral: Digital Education Group

Interventions

Digital Education Group BEHAVIORAL

Multimedia education provided to the intervention group via a digital tablet

Digital Education Group

Eligibility Criteria

• Age: 19 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients aged 19 years old or above
• Patients seen in outpatient clinic who are scheduled to undergo reconstructive head and neck surgeries for a confirmed oral or oropharyngeal cancer diagnosis.

You may not qualify if:

• Patients who are unable to use a digital tablet
• Patients who do not speak or read English
• Individuals unable to understand the purpose, methods and conduct of this study
• Patients unwilling to provide informed consent

Sponsors & Collaborators

• University of British Columbia: lead

Study Sites (1)

Vancouver General Hospital

Vancouver, British Columbia, Canada

Location

MeSH Terms

Conditions

Head and Neck Neoplasms; Patient Satisfaction

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Treatment Adherence and Compliance; Health Behavior; Behavior

Study Officials

• Eitan Prisman, MD, FRCSC

  University of British Columbia

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: CARE PROVIDER, INVESTIGATOR
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate Professor

Study Record Dates

• First Submitted: January 4, 2022
• First Posted: January 27, 2022
• Study Start: January 8, 2019
• Primary Completion: March 26, 2020
• Study Completion: June 1, 2022
• Last Updated: January 27, 2022

Record last verified: 2022-01

Data Sharing

• IPD Sharing: Will not share

Locations

CA (1)